Managing Heavy Menstrual Bleeding in Women at Risk of Thrombosis.
Clin Obstet Gynecol
; 61(2): 250-259, 2018 06.
Article
em En
| MEDLINE
| ID: mdl-29596075
ABSTRACT
Management of heavy menstrual bleeding (HMB) in a woman with a history of thrombosis, or who is otherwise at high risk of thrombosis, or who takes medications for anticoagulation can present a challenge to health care providers. The goal of treating HMB is to reduce menstrual blood loss. First-line therapy is typically hormonal, and hormonal therapy can be contraindicated in women with a history of thrombosis unless they are on anticoagulation. As 70% of women on anticoagulation experience HMB, successful management of HMB may involve a modification in the anticoagulation or antiplatelet regimen, hormonal therapy tailored to the patient's situation, and/or surgical therapy.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trombose
/
Menorragia
/
Anticoagulantes
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article